Glucuronide

A glucuronide is the conjugate formed when an enzyme attaches glucuronic acid to another molecule, making it water-soluble enough to excrete. The process — called glucuronidation — is one of the body's primary Phase II metabolic reactions, performed mainly in the liver by a family of enzymes known as UDP-glucuronosyltransferases (UGTs).

The liver is the chief site, but the gut wall, kidneys, and lungs also contribute. Because glucuronidation handles a broad range of substrates — prescription drugs, recreational compounds, hormones, environmental chemicals — glucuronides are among the most common metabolites found in human urine. Most are pharmacologically inactive; the body has, in effect, neutralised and watermarked the parent compound for removal.

How it works · its role

UGT enzymes transfer a glucuronic acid unit from a donor molecule (UDP-glucuronic acid) onto the target compound, bonding it at a hydroxyl, carboxyl, amine, or sulfur group. The resulting conjugate is far less lipophilic than its parent and clears primarily through the kidneys into urine, or through bile into the gut.

Conjugates excreted via bile do not always stay conjugated. Bacterial enzymes in the gut can cleave the glucuronic acid bond, freeing the parent compound to be reabsorbed — a cycle called enterohepatic recirculation. This loop can meaningfully extend how long a compound remains active in the body, even after the liver has nominally processed it.

Not every glucuronide is pharmacologically silent. Morphine-6-glucuronide, produced from morphine, binds to opioid receptors and produces opioid effects in its own right. In people with impaired kidney function, it clears more slowly than the parent compound and can accumulate — making the conjugate, not morphine itself, the dominant active species.

Relevance to substances & effects

Glucuronides are a practical consideration whenever a substance page discusses metabolism, detection windows, or the gap between plasma levels and observed effects.

For most substances, glucuronidation is the finishing step: the compound is rendered inactive and marked for elimination. But opioids illustrate that the conjugate can carry its own activity. Morphine-6-glucuronide has measurable affinity at the μ-opioid, and its accumulation in patients with poor renal clearance has been associated with prolonged or intensified opioid effects beyond what the morphine dose alone would predict.

Cannabis is the most widely encountered detection case. THC redistributes rapidly into fat tissue and leaves plasma quickly, but its glucuronide conjugates persist in urine for days to weeks depending on frequency of use and body composition. A positive urine screen identifies past exposure to the conjugate — it does not establish when the parent compound was taken, how much was used, or whether any impairment is present at the time of testing. Substance pages note this distinction specifically because detection window and duration of effect are separate questions.